Title: Pancreatic Extract
Additional Names: Pancreas powder
Trademarks: Creon (Solvay); Ku-Zyme (Schwarz); Pancrease (J & J); Pancrex-Vet (Pfizer); Panzytrat (Axcan); Ultrase (Axcan); Viokase (Axcan)
Literature References: Substance prepd from fresh or frozen mammalian pancreas, usually from swine, that contains various enzymes having proteolytic, lipolytic and amylolytic activities. Pharmacopeial specifications differ on the quantity of amylase, lipase and protease required; most commercial formulations are of higher digestive power. Method of production from cow or pig pancreas: S. Hoek, US 3223594 (1965 to N. American Philips). Clinical pharmacology and comparison of formulations: Y. W. Cho, D. M. Aviado, J. Clin. Pharmacol. 21, 224 (1981). Analysis of pharmaceutical preparations: C. L. Case et al., Pancreas 30, 180 (2005). Clinical trial in weight loss prevention in pancreatic cancer: M. J. Bruno et al., Gut 42, 92 (1998); in cystic fibrosis: R. C. Stern et al., Am. J. Gastroenterol. 95, 1932 (2000); C. J. Patchell et al., J. Cyst. Fibr. 1, 287 (2002).
Properties: Slightly brown, amorphous powder. Partly sol in water. Practically insol in alcohol, ether.
Derivative Type: Pancreatin
CAS Registry Number: 8049-47-6
Literature References: Pancreatic enzyme concentrate containing not less than 2 USP units of lipase, 25 of amylase and 25 of protease activities per mg. British Pharmacopeia specifies not less than 20 FIP units of lipase, 24 of amylase and 1.4 of protease activities per mg.
Derivative Type: Pancrelipase
CAS Registry Number: 53608-75-6
Literature References: Porcine pancreatic enzyme concentrate containing not less than 24 USP units of lipase, 100 of amylase and 100 of protease activities per mg.
Therap-Cat: Enzyme replacement therapy (pancreatic exocrine insufficiency).
Therap-Cat-Vet: Enzyme replacement therapy in pancreatic enzyme deficiency.
Keywords: Enzyme Replacement Therapy. |